Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TGTXTG THERAPEUTICS, INC.

Nasdaq · CIK 0001001316
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts474

Identity from submissions API

NameTG THERAPEUTICS, INC.
CIK0001001316
TickersTGTX
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN363898269
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(212) 554-4484
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • MANHATTAN PHARMACEUTICALS INC (2003-03-10T05:00:00.000Z → 2012-04-27T04:00:00.000Z)
  • ATLANTIC TECHNOLOGY VENTURES INC (2000-08-14T04:00:00.000Z → 2003-03-10T05:00:00.000Z)
  • ATLANTIC PHARMACEUTICALS INC (1996-11-07T05:00:00.000Z → 2000-02-04T05:00:00.000Z)
Business address
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
NY
Mailing address
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1151 filing rows loaded from submissions recent; extra archives: CIK0001001316-submissions-001.json (150 filings, 1996-07-03 to 2003-03-08).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-09 10-Q 10-Q 0001628280-26-072257 001-32639 261536522 34 7573822 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001628280-26-071870 001-32639 261533769 34 290435 1 1
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003853 005-51051 261491718 34 11314
2026-09-14 4 FORM 4 0001437749-26-030343 5524
2026-09-10 144 xsl144X01/primary_doc.xml 0001959173-26-006866 001-32639 261371741 33 4602
2026-08-07 4 FORM 4 0001437749-26-026608 8005
2026-08-05 10-Q FORM 10-Q 0001437749-26-025955 001-32639 261244582 34 7730823 1 1
2026-08-03 8-K FORM 8-K 2.02,9.01 0001437749-26-025304 001-32639 261230439 34 360155 1 1
2026-06-15 4 FORM 4 0001437749-26-020679 5953
2026-06-15 4 FORM 4 0001437749-26-020677 5922
2026-06-15 4 FORM 4 0001437749-26-020676 5927
2026-06-15 4 FORM 4 0001437749-26-020675 6001
2026-06-15 4 FORM 4 0001437749-26-020673 5959
2026-06-12 8-K FORM 8-K 5.07 0001437749-26-020491 001-32639 261087312 34 180460 1 1
2026-06-03 8-K FORM 8-K 8.01,9.01 0001437749-26-019262 001-32639 261058932 34 228252 1 1
2026-05-27 8-K FORM 8-K 8.01,9.01 0001437749-26-018586 001-32639 261026776 34 213703 1 1
2026-05-06 10-Q FORM 10-Q 0001437749-26-015246 001-32639 26949519 34 8570114 1 1
2026-05-06 8-K FORM 8-K 2.02,9.01 0001437749-26-015013 001-32639 26945813 34 307014 1 1
2026-04-30 DEF 14A FORM DEF 14A 0001437749-26-014233 001-32639 26926160 34 3248262 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000832 005-51051 26915464 34 7639
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002442 005-51051 26804832 34 7458
2026-03-20 8-K FORM 8-K 1.01,2.03,9.01 0001437749-26-009253 001-32639 26778686 34 169155 1 1
2026-02-27 10-K FORM 10-K 0001437749-26-006133 001-32639 26701542 34 10096076 1 1
2026-02-26 8-K FORM 8-K 2.02,9.01 0001437749-26-005733 001-32639 26681676 34 366650 1 1
2026-01-29 4 FORM 4 0001437749-26-002439 6429
2026-01-13 8-K FORM 8-K 7.01,9.01 0001437749-26-001194 001-32639 26530367 34 215226 1 1
2026-01-09 4 FORM 4 0001437749-26-001016 5265
2026-01-09 4 FORM 4 0001437749-26-001015 4839
2025-11-25 4 FORM 4 0001437749-25-036358 4909
2025-11-24 144 xsl144X01/primary_doc.xml 0001959173-25-007234 001-32639 251512866 33 4650
2025-11-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-25-000636 005-51051 251464658 34 8287
2025-11-07 4 FORM 4 0001437749-25-033888 6507
2025-11-05 10-Q FORM 10-Q 0001437749-25-033363 001-32639 251454560 34 7324104 1 1
2025-11-03 8-K FORM 8-K 2.02,9.01 0001437749-25-032658 001-32639 251442128 34 354282 1 1
2025-09-12 4 FORM 4 0001437749-25-028952 5390
2025-09-11 144 xsl144X01/primary_doc.xml 0001959173-25-005946 001-32639 251309138 33 4601
2025-08-08 S-8 FORM S-8 0001437749-25-025753 333-289478 251201483 33 240439 1 1
2025-08-08 S-3ASR FORM S-3ASR 0001437749-25-025771 333-289454 251199511 33 1039385 1 1
2025-08-08 10-Q FORM 10-Q 0001437749-25-025745 001-32639 251199060 34 6977815 1 1
2025-08-04 8-K FORM 8-K 2.02,9.01 0001437749-25-024480 001-32639 251178017 34 344030 1 1
2025-06-16 4 FORM 4 0001437749-25-020546 6916
2025-06-16 4 FORM 4 0001437749-25-020545 4805
2025-06-16 4 FORM 4 0001437749-25-020543 4773
2025-06-16 4 FORM 4 0001437749-25-020541 4768
2025-06-16 4 FORM 4 0001437749-25-020540 4799
2025-06-13 8-K FORM 8-K 5.07,9.01 0001437749-25-020335 001-32639 251047416 34 174124 1 1
2025-06-13 144 xsl144X01/primary_doc.xml 0001959173-25-004055 001-32639 251045482 33 4611
2025-05-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-25-000323 005-51051 25938581 34 8325
2025-05-09 10-Q FORM 10-Q 0001437749-25-015804 001-32639 25930976 34 6308814 1 1
2025-05-05 8-K FORM 8-K 2.02,9.01 0001437749-25-014402 001-32639 25910926 34 312876 1 1
2025-04-30 ARS ARS 0001437749-25-013863 001-32639 25895697 34 1858485
2025-04-30 DEFA14A FORM DEFA14A 0001437749-25-013861 001-32639 25895665 34 247502
2025-04-30 DEF 14A FORM DEF 14A 0001437749-25-013860 001-32639 25895651 34 2892231 1 1
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002013 005-51051 25893020 34 11395
2025-04-18 PRE 14A FORM PRE 14A 0001437749-25-012371 001-32639 25850553 34 2917881 1 1
2025-03-18 4 FORM 4 0001437749-25-008284 4813
2025-03-11 4 FORM 4 0001437749-25-007052 4827
2025-03-03 10-K FORM 10-K 0001437749-25-005908 001-32639 25697659 34 9508493 1 1
2025-03-03 8-K FORM 8-K 2.02,9.01 0001437749-25-005802 001-32639 25693770 34 354952 1 1
2025-01-30 4 FORM 4 0001437749-25-002292 5273
2025-01-30 4 FORM 4 0001437749-25-002290 4846
2025-01-14 8-K FORM 8-K 7.01,9.01 0001437749-25-001106 001-32639 25529379 34 207633 1 1
2025-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000038 005-51051 25517198 34 6563
2025-01-07 4 FORM 4 0001437749-25-000662 6577
2025-01-06 144 xsl144X01/primary_doc.xml 0001959173-25-000144 001-32639 25511093 33 5353
2025-01-03 144 xsl144X01/primary_doc.xml 0001959173-25-000097 001-32639 25507350 33 4721
2024-11-14 SC 13G/A TG THERAPEUTICS, INC 0000902664-24-006638 005-51051 241465280 34 71443
2024-11-12 4 FORM 4 0001437749-24-034597 4659
2024-11-12 4 FORM 4 0001437749-24-034595 6769
2024-11-12 144/A xsl144X01/primary_doc.xml 0001959173-24-007724 001-32639 241446205 33 4838
2024-11-12 144 xsl144X01/primary_doc.xml 0001959173-24-007713 001-32639 241445594 33 4649
2024-11-12 144 xsl144X01/primary_doc.xml 0001959173-24-007703 001-32639 241445411 33 4607
2024-11-07 4 FORM 4 0001437749-24-033950 4883
2024-11-07 10-Q FORM 10-Q 0001437749-24-033948 001-32639 241436422 34 7801176 1 1
2024-11-05 144 xsl144X01/primary_doc.xml 0001959173-24-007410 001-32639 241426795 33 5145
2024-11-04 8-K FORM 8-K 2.02,9.01 0001437749-24-033055 001-32639 241420748 34 335890 1 1
2024-10-07 SC 13G/A us88322q1085_100724.txt 0002012383-24-000117 005-51051 241357881 34 14015
2024-08-09 10-Q FORM 10-Q 0001437749-24-025853 001-32639 241192503 34 8237641 1 1
2024-08-09 10-K/A FORM 10-K/A 0001437749-24-025850 001-32639 241192457 34 341893 1 1
2024-08-06 8-K FORM 8-K 1.01,1.02,2.02,8.01,9.01 0001437749-24-024718 001-32639 241177060 34 357348 1 1
2024-06-20 4 FORM 4 0001437749-24-020851 7867
2024-06-20 4 FORM 4 0001437749-24-020850 4775
2024-06-20 4 FORM 4 0001437749-24-020849 4780
2024-06-20 4 FORM 4 0001437749-24-020848 4820
2024-06-20 4 FORM 4 0001437749-24-020847 4812
2024-06-20 144 xsl144X01/primary_doc.xml 0001959173-24-004568 001-32639 241057363 33 5395
2024-06-20 144 xsl144X01/primary_doc.xml 0001959173-24-004558 001-32639 241056065 33 5394
2024-06-17 8-K FORM 8-K 5.02,5.03,5.07,9.01 0001437749-24-020510 001-32639 241048941 34 219481 1 1
2024-06-17 144 xsl144X01/primary_doc.xml 0001959173-24-004473 001-32639 241047898 33 4758
2024-06-13 PX14A6G tgtx24shletter.htm 0002021815-24-000006 001-32639 241039752 34 26675
2024-06-10 PX14A6G CALSTRS FORM PX14A6G 0000950159-24-000214 001-32639 241031864 34 34939
2024-05-06 10-Q FORM 10-Q 0001437749-24-014849 001-32639 24918409 34 5885371 1 1
2024-05-01 8-K FORM 8-K 2.02,9.01 0001437749-24-014062 001-32639 24900029 34 283764 1 1
2024-04-29 ARS tgtx_ars.pdf 0001437749-24-013742 001-32639 24892369 34 1017622
2024-04-29 DEFA14A FORM DEFA14A 0001437749-24-013721 001-32639 24891669 34 755742
2024-04-29 DEF 14A FORM DEF 14A 0001437749-24-013719 001-32639 24891544 34 3121969 1 1
2024-04-18 PRE 14A FORM PRE 14A 0001437749-24-012456 001-32639 24854889 34 2007527 1 1
2024-03-15 4 FORM 4 0001437749-24-008124 4659
2024-03-13 4 FORM 4 0001437749-24-007662 5405
2024-03-13 144 xsl144X01/primary_doc.xml 0001959173-24-002302 001-32639 24746011 33 4602
2024-03-12 144 xsl144X01/primary_doc.xml 0001959173-24-002239 001-32639 24740813 33 5254
2024-02-29 10-K FORM 10-K 0001437749-24-006144 001-32639 24705218 34 10192286 1 1
2024-02-28 8-K FORM 8-K 2.02,9.01 0001437749-24-005802 001-32639 24690164 34 337151 1 1
2024-02-14 5 FORM 5 0001437749-24-004259 4894
2024-02-14 SC 13G/A TG THERAPEUTICS, INC. 0000902664-24-001654 005-51051 24636843 34 77143
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-022090 005-51051 24629672 34 13359
2024-01-26 SC 13G/A us88322q1085_012624.txt 0001086364-24-004661 005-51051 24568125 34 13941
2024-01-25 SC 13G/A TGTherapeutics.txt 0000093751-24-000239 005-51051 24560142 34 8815
2024-01-10 8-K FORM 8-K 1.01,7.01,9.01 0001437749-24-001061 001-32639 24524876 34 215168 1 1
2024-01-08 4 FORM 4 0001437749-24-000900 5646
2024-01-08 4 FORM 4 0001437749-24-000899 5074
2024-01-05 4 FORM 4 0001437749-24-000756 6768
2024-01-05 144 xsl144X01/primary_doc.xml 0001959173-24-000142 001-32639 24514954 33 4610
2024-01-03 144 xsl144X01/primary_doc.xml 0001959173-24-000096 001-32639 24507514 33 4564
2023-11-06 10-Q FORM 10-Q 0001437749-23-030412 001-32639 231380660 34 5974652 1 1
2023-11-01 8-K FORM 8-K 2.02,9.01 0001437749-23-029660 001-32639 231366577 34 297913 1 1
2023-09-29 4 OWNERSHIP DOCUMENT 0001104659-23-105403 5117
2023-09-29 4 OWNERSHIP DOCUMENT 0001104659-23-105400 5086
2023-09-29 4 OWNERSHIP DOCUMENT 0001104659-23-105394 5091
2023-09-29 4 OWNERSHIP DOCUMENT 0001104659-23-105389 5131
2023-09-29 4 OWNERSHIP DOCUMENT 0001104659-23-105383 5123
2023-08-14 4 OWNERSHIP DOCUMENT 0001104659-23-091054 5665
2023-08-04 10-Q 10-Q 0001558370-23-013429 001-32639 231144460 34 6930214 1 1
2023-08-01 8-K 8-K 1.01,2.02,9.01 0001558370-23-012631 001-32639 231129658 34 460593 1 1
2023-06-26 4 OWNERSHIP DOCUMENT 0001104659-23-074784 5441
2023-06-23 144 xsl144X01/primary_doc.xml 0001959173-23-002082 001-32639 231038050 33 4529
2023-06-15 8-K 8-K 5.07 0001558370-23-011140 001-32639 231017790 34 174320 1 1
2023-06-05 4 OWNERSHIP DOCUMENT 0001104659-23-068182 5418
2023-06-02 144 xsl144X01/primary_doc.xml 0001959173-23-001512 001-32639 23990034 33 4480
2023-05-08 10-Q 10-Q 0001558370-23-008385 001-32639 23895898 34 7148437 1 1
2023-05-01 DEFA14A DEFA14A 0001558370-23-007492 001-32639 23873965 34 396192
2023-05-01 DEF 14A DEF 14A 0001558370-23-007490 001-32639 23873928 34 2140596 1 1
2023-05-01 8-K 8-K 2.02,9.01 0001558370-23-007393 001-32639 23870032 34 282007 1 1
2023-04-21 PRE 14A PRE 14A 0001558370-23-006442 001-32639 23836758 34 1571102 1 1
2023-04-03 SC 13G TG THERAPEUTICS, INC. 0000902664-23-002440 005-51051 23790670 34 79696
2023-03-14 4 OWNERSHIP DOCUMENT 0001104659-23-032338 5158
2023-03-14 4 OWNERSHIP DOCUMENT 0001104659-23-032337 5326
2023-03-01 10-K 10-K 0001558370-23-002610 001-32639 23695062 34 8862110 1 1
2023-02-28 8-K 8-K 2.02,9.01 0001558370-23-002239 001-32639 23678390 34 345685 1 1
2023-02-09 SC 13G/A filing.txt 0000315066-23-002127 005-51051 23605094 34 8463
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-017095 005-51051 23604424 34 13265
2023-02-03 SC 13G/A TG_Therapeutics_Inc.txt 0000093751-23-000195 005-51051 23586163 34 10646
2023-02-01 SC 13G/A us88322q1085_020123.txt 0001306550-23-006375 005-51051 23577521 34 13678
2023-01-06 4 OWNERSHIP DOCUMENT 0001104659-23-001901 4942
2023-01-06 4 OWNERSHIP DOCUMENT 0001104659-23-001900 5869
2022-12-28 8-K 8-K 8.01,9.01 0001558370-22-019019 001-32639 221494961 34 238957 1 1
2022-11-10 8-K 8-K 2.02,9.01 0001558370-22-017292 001-32639 221374975 34 317608 1 1
2022-11-09 10-Q 10-Q 0001558370-22-017180 001-32639 221373152 34 5866210 1 1
2022-10-11 SC 13G/A SCHEDULE 13G/A 0001104659-22-107554 005-51051 221302818 34 13266
2022-09-02 S-3ASR S-3ASR 0001558370-22-014178 333-267262 221225570 33 1136969
2022-08-09 10-Q 10-Q 0001558370-22-012854 001-32639 221148078 34 5767241 1 1
2022-08-08 8-K 8-K 2.02,9.01 0001558370-22-012517 001-32639 221142583 34 335965 1 1
2022-07-22 4 OWNERSHIP DOCUMENT 0001104659-22-082027 5610
2022-07-22 4 OWNERSHIP DOCUMENT 0001104659-22-082024 7791
2022-07-22 4 OWNERSHIP DOCUMENT 0001104659-22-082023 5077
2022-07-22 4 OWNERSHIP DOCUMENT 0001104659-22-082022 5046
2022-07-22 4 OWNERSHIP DOCUMENT 0001104659-22-082020 5051
2022-07-22 4 OWNERSHIP DOCUMENT 0001104659-22-082018 5091
2022-07-22 4 OWNERSHIP DOCUMENT 0001104659-22-082016 5083
2022-07-11 SC 13G/A filing.txt 0000315066-22-001661 005-51051 221075940 34 8094
2022-06-24 S-8 S-8 0001558370-22-010281 333-265838 221040883 33 166063
2022-06-23 8-K 8-K 5.07,9.01 0001558370-22-010227 001-32639 221035871 34 347079 1 1
2022-05-10 10-Q 10-Q 0001558370-22-008130 001-32639 22910217 34 5180592 1 1
2022-04-29 DEFA14A DEFA14A 0001558370-22-006485 001-32639 22875463 34 462182
2022-04-29 DEF 14A DEF 14A 0001558370-22-006479 001-32639 22875188 34 1436840
2022-04-18 8-K 8-K 8.01,9.01 0001558370-22-005537 001-32639 22831018 34 187434 1 1
2022-03-01 10-K 10-K 0001558370-22-002617 001-32639 22699772 34 10076496 1 1
2022-03-01 8-K 8-K 2.02,9.01 0001558370-22-002470 001-32639 22694093 34 311652 1 1
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018707 005-51051 22611019 34 13259
2022-02-09 SC 13G/A filing.txt 0000315066-22-001198 005-51051 22604604 34 8772
2022-02-01 SC 13G/A us88322q1085_020122.txt 0000834237-22-004463 005-51051 22579885 34 13702
2022-01-27 8-K 8-K 8.01,9.01 0001558370-22-000487 001-32639 22560546 34 157656 1 1
2022-01-07 4 OWNERSHIP DOCUMENT 0001104659-22-002361 7048
2022-01-07 4 OWNERSHIP DOCUMENT 0001104659-22-002355 14171
2022-01-04 8-K 8-K 1.01,9.01 0001558370-22-000026 001-32639 22504075 34 155335 1 1
2021-11-30 8-K 8-K 8.01,9.01 0001558370-21-016373 001-32639 211458316 34 201076 1 1
2021-11-08 10-Q 10-Q 0001558370-21-015039 001-32639 211388161 34 6149854 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001558370-21-014445 001-32639 211378004 34 347846 1 1
2021-08-06 10-Q 10-Q 0001558370-21-010837 001-32639 211153666 34 6047472 1 1
2021-08-02 8-K 8-K 2.02,9.01 0001558370-21-009752 001-32639 211134729 34 338541 1 1
2021-06-23 8-K 8-K 5.02 0001558370-21-008523 001-32639 211036598 34 154640 1 1
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084262 5313
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084261 5562
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084260 5083
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084259 5046
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084258 5051
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084257 5091
2021-06-22 4 OWNERSHIP DOCUMENT 0001104659-21-084256 6749
2021-06-21 8-K 8-K 5.03,5.07,9.01 0001558370-21-008482 001-32639 211032079 34 194032 1 1
2021-05-10 10-Q 10-Q 0001558370-21-006712 001-32639 21908201 34 5784025 1 1
2021-05-10 8-K 8-K 2.02,9.01 0001558370-21-006573 001-32639 21905226 34 285510 1 1
2021-04-30 DEFA14A DEFA14A 0001558370-21-005394 001-32639 21877720 34 370363
2021-04-30 DEF 14A DEF 14A 0001558370-21-005391 001-32639 21877642 34 1181981
2021-04-20 PRE 14A PRE 14A 0001558370-21-004519 001-32639 21838614 34 692930
2021-04-16 8-K 8-K 8.01,9.01 0001558370-21-004378 001-32639 21830118 34 207200 1 1
2021-04-13 8-K 8-K 4.01,9.01 0001558370-21-004233 001-32639 21823375 34 162166 1 1
2021-03-02 8-K 8-K 2.02,9.01 0001558370-21-002218 001-32639 21701269 34 337859 1 1
2021-03-01 10-K 10-K 0001558370-21-002149 001-32639 21697622 34 9257802 1 1
2021-02-16 SC 13G/A greatpoint-tgtx123020a1.htm 0001172661-21-000718 005-51051 21638544 34 77636
2021-02-12 5 FORM 5 0001104659-21-022085 6910
2021-02-10 SC 13G/A SC 13G/A 0001104659-21-019883 005-51051 21614682 34 88208
2021-02-10 SC 13G/A SC 13G/A 0001104659-21-019852 005-51051 21614378 34 86713
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-019225 005-51051 21612150 34 14102
2021-02-08 SC 13G/A filing.txt 0000315066-21-001295 005-51051 21599844 34 8733
2021-02-08 8-K 8-K 8.01,9.01 0001558370-21-000791 001-32639 21598508 34 206835 1 1
2021-02-01 SC 13G/A us88322q1085_013121.txt 0000834237-21-005702 005-51051 21574743 34 13712
2021-01-04 4 OWNERSHIP DOCUMENT 0001104659-21-000339 5155
2020-12-31 5 OWNERSHIP DOCUMENT 0001104659-20-140992 16199
2020-12-16 8-K FORM 8-K 1.01,9.01 0001104659-20-136290 001-32639 201392610 34 518070 1 1
2020-12-16 424B5 424B5 0001104659-20-136281 333-233636 201392546 33 1076876
2020-12-14 424B5 424B5 0001104659-20-135051 333-233636 201385135 33 1061031
2020-12-11 4 OWNERSHIP DOCUMENT 0001104659-20-134811 5354
2020-12-10 8-K 8-K 8.01,9.01 0001558370-20-014296 001-32639 201379499 34 187236 1 1
2020-12-08 8-K 8-K 8.01,9.01 0001558370-20-014242 001-32639 201374423 34 221694 1 1
2020-11-09 8-K 8-K 2.02,9.01 0001558370-20-013426 001-32639 201298856 34 306657 1 1
2020-11-09 8-K 8-K 8.01,9.01 0001558370-20-013424 001-32639 201298821 34 197735 1 1
2020-11-09 424B5 424B5 0001558370-20-013420 333-233636 201298713 33 353199
2020-11-09 10-Q 10-Q 0001558370-20-013410 001-32639 201298624 34 7008352 1 1
2020-11-05 8-K 8-K 8.01,9.01 0001558370-20-012661 001-32639 201288337 34 205677 1 1
2020-09-11 4 OWNERSHIP DOCUMENT 0001104659-20-104436 10081
2020-08-10 10-Q 10-Q 0001558370-20-010225 001-32639 201090105 34 6884502 1 1
2020-08-10 8-K FORM 8-K 2.02,9.01 0001104659-20-092406 001-32639 201087088 34 281817 1 1
2020-07-20 4 OWNERSHIP DOCUMENT 0001104659-20-084949 6932
2020-07-02 4 OWNERSHIP DOCUMENT 0001104659-20-080595 5184
2020-07-02 3 OWNERSHIP DOCUMENT 0001104659-20-080593 11471
2020-06-24 4 OWNERSHIP DOCUMENT 0001104659-20-076547 5826
2020-06-24 4 OWNERSHIP DOCUMENT 0001104659-20-076546 5041
2020-06-24 4 OWNERSHIP DOCUMENT 0001104659-20-076545 5046
2020-06-24 4 OWNERSHIP DOCUMENT 0001104659-20-076544 5086
2020-06-24 4 OWNERSHIP DOCUMENT 0001104659-20-076543 5075
2020-06-24 4 OWNERSHIP DOCUMENT 0001104659-20-076542 7490
2020-06-24 8-K 8-K 5.02,5.07,9.01 0001558370-20-007744 001-32639 20986284 34 195123 1 1
2020-06-10 SC 13G/A SC 13G/A 0001104659-20-072021 005-51051 20954854 34 61582
2020-06-10 SC 13G filing.txt 0000315066-20-001583 005-51051 20953750 34 8623
2020-05-29 PX14A6G PX14A6G 0001140361-20-012674 001-32639 20925130 34 31748
2020-05-18 8-K 8-K 1.01,9.01 0001558370-20-006811 001-32639 20890438 34 594553 1 1
2020-05-18 424B5 424B5 0001558370-20-006795 333-233636 20889464 33 1164747
2020-05-14 424B5 424B5 0001558370-20-006630 333-233636 20879014 33 1145058
2020-05-11 8-K 8-K 2.02,9.01 0001558370-20-006314 001-32639 20866045 34 276355 1 1
2020-05-11 10-Q 10-Q 0001558370-20-006304 001-32639 20865962 34 6361220 1 1
2020-05-07 3 OWNERSHIP DOCUMENT 0001104659-20-058131 12678
2020-05-05 8-K 8-K 8.01,9.01 0001558370-20-005097 001-32639 20846853 34 175147 1 1
2020-04-30 8-K 8-K 5.02,9.01 0001558370-20-004722 001-32639 20833156 34 173027 1 1
2020-04-29 DEFA14A DEFA14A 0001558370-20-004651 001-32639 20830842 34 720778
2020-04-29 DEF 14A DEF 14A 0001558370-20-004647 001-32639 20830801 34 1006944
2020-03-20 424B5 424B5 0001558370-20-002997 333-233636 20732617 33 483390
2020-03-20 8-K 8-K 8.01,9.01 0001558370-20-002992 001-32639 20732440 34 589115 1 1
2020-03-03 8-K 8-K 2.02,9.01 0001558370-20-001925 001-32639 20679944 34 362073 1 1
2020-03-02 10-K 10-K 0001558370-20-001897 001-32639 20677318 34 9591482 1 1
2020-02-14 SC 13G/A SC 13G/A 0001104659-20-021910 005-51051 20620913 34 61725
2020-02-14 SC 13G/A SCHEDULE 13G HOLDINGS REPORT AMENDMENT 0001172661-20-000786 005-51051 20619115 34 73884
2020-02-14 SC 13G/A TG THERAPEUTICS, INC. 0000902664-20-001111 005-51051 20614899 34 57365
2020-02-13 SC 13G/A TGTherapeuticsInc.txt 0000093751-20-000475 005-51051 20610003 34 8796
2020-02-07 SC 13G us88322q1085_020620.txt 0000834237-20-008183 005-51051 20584818 34 13541
2020-01-24 SC 13G/A TGTX_SC13GA1.htm 0001319244-20-000018 005-51051 20545606 34 128931
2020-01-02 SC 13G SCHEDULE 13G 0001172661-20-000001 005-51051 20500900 34 81210
2019-12-26 8-K 8-K 8.01,9.01 0001654954-19-014209 001-32639 191308426 34 284692 1 1
2019-12-23 424B5 424B5 0001654954-19-014167 333-233636 191303441 33 25681
2019-12-09 8-K CURRENT REPORT 8.01,9.01 0001654954-19-013703 001-32639 191274373 34 225279 1 1
2019-11-12 10-Q 10-Q 0001654954-19-012751 001-32639 191210965 34 5329583 1 1
2019-11-12 8-K 8-K 2.02,9.01 0001654954-19-012611 001-32639 191206122 34 297268 1 1
2019-10-28 8-K 8-K 8.01,9.01 0001654954-19-012023 001-32639 191171170 34 176514 1 1
2019-09-18 4 FORM 4 0001654954-19-010891 4798
2019-09-18 4 FORM 4 0001654954-19-010890 4834
2019-09-18 4 FORM 4 0001654954-19-010888 4838
2019-09-18 4 FORM 4 0001654954-19-010886 4858
2019-09-18 4 FORM 4 0001654954-19-010885 4791
2019-09-12 8-K FORM 8-K 8.01,9.01 0001654954-19-010620 001-32639 191089630 34 175904 1 1
2019-09-05 S-3ASR FORM S-3ASR 0001654954-19-010402 333-233636 191077388 33 1077460
2019-09-05 RW FORM RW 0001654954-19-010400 333-233565 191077197 NE 16132
2019-08-30 S-3 S-3 0001654954-19-010203 333-233565 191069731 33 1000211
2019-08-09 10-Q FORM 10-Q 0001654954-19-009176 001-32639 191013371 34 6442668 1 1
2019-08-09 8-K 8-K 2.02,9.01 0001654954-19-009109 001-32639 191011314 34 161670
2019-07-03 4 FORM4 0001654954-19-007935 5606
2019-06-27 4 FORM4 0001654954-19-007706 5285
2019-06-14 4 FORM4 0001654954-19-007359 5619
2019-06-13 8-K 8-K 5.07 0001654954-19-007297 001-32639 19896175 34 59796
2019-06-07 SC 13G/A us88322q1085_060719.txt 0000215457-19-008047 005-51051 19886637 34 12697
2019-05-31 PX14A6G PX14A6G 0001140361-19-010173 001-32639 19870018 34 38441
2019-05-10 10-Q 10Q 0001654954-19-005680 001-32639 19814766 34 3830343 1
2019-05-10 8-K 8-K 2.02,9.01 0001654954-19-005592 001-32639 19812800 34 115873
2019-05-08 8-K 8-K 8.01,9.01 0001654954-19-005419 001-32639 19804638 34 40866
2019-04-30 DEFA14A DEFA14A 0001654954-19-005037 001-32639 19782356 34 396180
2019-04-30 DEF 14A DEF14A 0001654954-19-005036 001-32639 19782278 34 861136
2019-04-01 8-K 8-K 8.01,9.01 0001654954-19-003766 001-32639 19718897 34 65707
2019-03-11 SC 13G SCHEDULE 13G HOLDINGS REPORT 0001172661-19-000927 005-51051 19672339 34 73821
2019-03-07 SC 13G TGTX_SC13G.htm 0001319244-19-000034 005-51051 19666639 34 97558
2019-03-05 424B5 424B5 0001654954-19-002274 333-218293 19656789 33 773615
2019-03-05 8-K 8-K 1.01,8.01,9.01 0001654954-19-002276 001-32639 19656785 34 1319755
2019-03-01 10-K 10-K 0001654954-19-002189 001-32639 19650197 34 5367098 1
2019-02-28 424B5 424B5 0001654954-19-002091 333-218293 19643107 33 602445
2019-02-28 8-K 8-K 8.01,9.01 0001654954-19-002047 001-32639 19640460 34 52676
2019-02-14 SC 13G SC 13G 0001144204-19-008306 005-51051 19608214 34 49537
2019-02-14 SC 13G/A SCHEDULE 13G HOLDINGS REPORT AMENDMENT 0001172661-19-000823 005-51051 19606225 34 73782
2019-02-14 SC 13G TG THERAPEUTICS, INC. 0000093751-19-000238 005-51051 19601125 34 8840
2019-02-14 SC 13G TG THERAPEUTICS, INC. 0000902664-19-001008 005-51051 19600953 34 62906
2019-02-13 SC 13G/A filing.txt 0000315066-19-001380 005-51051 19595217 34 8641
2019-02-08 SC 13G us88322q1085_020719.txt 0000215457-19-006548 005-51051 19576369 34 13541
2019-01-22 8-K 8-K 8.01,9.01 0001654954-19-000641 001-32639 19534321 34 39810
2019-01-03 4 FORM-4 0001654954-19-000085 7535
2018-12-04 8-K 8-K 8.01,9.01 0001654954-18-013524 001-32639 181215394 34 58515
2018-11-09 10-Q 10-Q 0001654954-18-012303 001-32639 181173028 34 3372353 1
2018-11-09 8-K 8-K 2.02,9.01 0001654954-18-012263 001-32639 181171372 34 152970
2018-10-15 8-K 8-K 8.01,9.01 0001654954-18-011171 001-32639 181123083 34 46666
2018-09-25 8-K 8-K 8.01 0001654954-18-010436 001-32639 181084669 34 42698
2018-09-18 CT ORDER filename1.pdf 20180917,20180918 9999999997-18-007926 001-32639 181073015 34 17503
2018-08-09 10-Q 10-Q 0001654954-18-008750 001-32639 181005528 34 3935928 1
2018-08-07 8-K 8-K 2.02,9.01 0001654954-18-008559 001-32639 18997985 34 153458
2018-07-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-07-23 09:00:00 9999999995-18-001856 333-226097 18965540 33 2005
2018-07-18 CORRESP filename1.htm 0001654954-18-007816 13943
2018-07-17 UPLOAD filename1.pdf 0000000000-18-021923 45000
2018-07-11 SC 13D/A SC 13D/A 0001193125-18-215834 005-51051 18948105 34 149643
2018-07-09 S-3 S-3 0001654954-18-007460 333-226097 18945274 33 228702
2018-07-05 4 FORM-4 0001654954-18-007370 6660
2018-07-02 4 FORM-4 0001654954-18-007267 4829
2018-06-28 4 FORM4 0001654954-18-007121 4796
2018-06-28 4 FORM-4 0001654954-18-007120 4856
2018-06-28 4 FORM-4 0001654954-18-007119 5579
2018-06-28 4 FORM4 0001654954-18-007118 4790
2018-06-28 4 FORM4 0001654954-18-007116 4836
2018-06-28 4 FORM4 0001654954-18-007117 4813
2018-06-25 S-8 S-8 0001654954-18-006935 333-225868 18917347 33 110874
2018-06-20 8-K 8-K 1.01 0001654954-18-006777 001-32639 18908668 34 24629
2018-06-18 SC 13D/A SC 13D AMENDMENT NO. 2 0001193125-18-195773 005-51051 18905328 34 41093
2018-06-18 8-K 8-K 8.01,9.01 0001654954-18-006743 001-32639 18904993 34 58698
2018-06-18 4 FORM-4 0001654954-18-006742 4710
2018-06-15 8-K 8-K 8.01,9.01 0001654954-18-006703 001-32639 18902572 34 63528
2018-06-13 8-K 8-K 5.07 0001654954-18-006609 001-32639 18897087 34 47971
2018-06-07 8-K 8-K 8.01,9.01 0001654954-18-006381 001-32639 18886814 34 3192289
2018-06-04 8-K 8-K 8.01,9.01 0001654954-18-006261 001-32639 18878542 34 1441632
2018-05-10 10-Q 10-Q 0001654954-18-005046 001-32639 18822351 34 3173646 1
2018-05-08 8-K 8-K 2.02,9.01 0001654954-18-004821 001-32639 18812972 34 107649
2018-04-30 CT ORDER filename1.pdf 20180430,20180430 9999999997-18-005345 001-32639 18790983 34 17497
2018-04-30 DEFA14A PROXY NOTICE CARD 0001654954-18-004521 001-32639 18789553 34 299368
2018-04-30 DEF 14A DEF14A 0001654954-18-004519 001-32639 18789532 34 904794
2018-04-24 8-K 8-K 8.01,9.01 0001654954-18-004295 001-32639 18771757 34 42729
2018-03-15 10-K 10-K 0001654954-18-002638 001-32639 18693479 34 6078875 1
2018-03-08 8-K 8-K 2.02,9.01 0001654954-18-002262 001-32639 18675018 34 146704
2018-02-14 SC 13G/A 13G/A 0001172661-18-000780 005-51051 18612474 34 73582
2018-02-13 SC 13G/A filing.txt 0000315066-18-001636 005-51051 18600172 34 9691
2018-02-02 8-K V020218_8K 8.01 0001654954-18-001025 001-32639 18568853 34 42699
2018-01-08 8-K 8-K 1.01 0001654954-18-000169 001-32639 18515113 34 27625
2018-01-03 4 FORM-4 0001654954-18-000068 7090
2017-12-11 8-K 8-K 8.01,9.01 0001654954-17-011485 001-32639 171249647 34 60282
2017-11-09 10-Q 10-Q 0001654954-17-010322 001-32639 171191344 34 3096600 1
2017-11-08 8-K 8-K 2.02,9.01 0001654954-17-010173 001-32639 171185079 34 147013
2017-10-27 8-K 8-K 8.01,9.01 0001654954-17-009767 001-32639 171159606 34 67277
2017-10-17 8-K 8-K 8.01,9.01 0001654954-17-009506 001-32639 171141001 34 88419
2017-09-05 8-K 8-K 8.01,9.01 0001654954-17-008143 001-32639 171069391 34 45969
2017-08-10 8-K 8-K 8.01,9.01 0001654954-17-007238 001-32639 171021839 34 44511
2017-08-09 10-Q 10-Q 0001654954-17-007129 001-32639 171017891 34 3069180 1
2017-08-09 8-K 8-K 2.02,9.01 0001654954-17-007087 001-32639 171016461 34 154576
2017-08-01 8-K 8-K 8.01,9.01 0001654954-17-006791 001-32639 17994965 34 46347 1 1
2017-06-21 8-K 8-K 5.07 0001654954-17-005749 001-32639 17922130 34 46311
2017-06-19 4 FORM-4 0001654954-17-005710 7277
2017-06-19 4 FORM4 0001654954-17-005708 4853
2017-06-19 4 FORM4 0001654954-17-005707 4830
2017-06-19 4 FORM4 0001654954-17-005706 4794
2017-06-19 4 FORM4 0001654954-17-005705 4788
2017-06-19 4 FORM4 0001654954-17-005704 4835
2017-06-19 4 FORM4 0001654954-17-005703 4812
2017-06-19 4 FORM4 0001654954-17-005702 6701
2017-06-16 8-K 8-K 8.01,9.01 0001654954-17-005627 001-32639 17914826 34 114021
2017-06-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2017-06-13 11:00:00 9999999995-17-001522 333-218293 17910205 33 2005
2017-06-09 CORRESP filename1.htm 0001654954-17-005480 12808
2017-06-09 S-3/A S-3 0001654954-17-005478 333-218293 17903129 33 415009
2017-06-05 8-K 8-K 8.01,9.01 0001654954-17-005338 001-32639 17890073 34 94282
2017-05-26 S-3 S-3 0001654954-17-005148 333-218293 17874392 33 1361601
2017-05-24 8-K 8-K 8.01,9.01 0001654954-17-005058 001-32639 17866670 34 47470
2017-05-10 10-Q 10-Q 0001654954-17-004345 001-32639 17830474 34 2963713 1
2017-05-05 8-K 8-K 2.02,9.01 0001654954-17-004080 001-32639 17816089 34 114086
2017-05-01 8-K 8-K 8.01,9.01 0001654954-17-003837 001-32639 17801161 34 48175
2017-04-28 DEF 14A PRIMARY DOCUMENT 0001654954-17-003773 001-32639 17795293 34 791776
2017-04-12 4 FORM4 0001654954-17-003280 4901
2017-04-10 SC 13G/A filing.txt 0000315066-17-002291 005-51051 17752104 34 9640
2017-04-04 4 FORM4 0001654954-17-003070 4881
2017-03-21 10-K/A 10-K/A 0001654954-17-002229 001-32639 17704593 34 274271
2017-03-16 10-K 10-K 0001654954-17-002050 001-32639 17692383 34 5359271 1
2017-03-10 424B5 424B5 0001144204-17-013988 333-201339 17682190 33 633626
2017-03-10 8-K 8-K 8.01,9.01 0001654954-17-001836 001-32639 17680185 34 156667
2017-03-09 8-K 8-K 1.01,8.01,9.01 0001144204-17-013738 001-32639 17679225 34 350886
2017-03-08 424B5 424B5 0001144204-17-013451 333-201339 17675095 33 624708
2017-03-06 8-K FORM 8-K 8.01,9.01 0001654954-17-001669 001-32639 17666473 34 58161
2017-02-14 SC 13G/A SC 13G/A 0001144204-17-009123 005-51051 17612232 34 56475
2017-02-14 SC 13G/A ja13ga2-tg_bridger.htm 0000895345-17-000091 005-51051 17609399 34 81496
2017-02-14 SC 13G/A filing.txt 0000315066-17-002091 005-51051 17605493 34 9648
2017-01-04 4 PRIMARY DOCUMENT 0001354488-17-000035 7095
2017-01-04 4 PRIMARY DOCUMENT 0001354488-17-000033 10529
2017-01-04 8-K FORM 8-K 5.02 0001654954-17-000064 001-32639 17506008 34 27611
2016-12-06 8-K FORM 8-K 8.01 0001654954-16-004637 001-32639 162036643 34 71090
2016-12-05 8-K FORM 8-K 8.01 0001654954-16-004586 001-32639 162034143 34 74414
2016-11-09 10-Q 10-Q 0001654954-16-003692 001-32639 161984162 34 3097922 1
2016-11-07 8-K 8-K 2.02,9.01 0001654954-16-003547 001-32639 161976582 34 165254
2016-10-13 8-K FORM 8-K 8.01,9.01 0001654954-16-002790 001-32639 161934062 34 53107
2016-10-04 CT ORDER filename1.pdf 20161004,20161004 9999999997-16-026301 001-32639 161918271 34 13893
2016-09-01 4 PRIMARY DOCUMENT 0001354488-16-008247 5406
2016-08-09 10-Q 10-Q 0001654954-16-001302 001-32639 161817797 34 3382190 1
2016-08-08 8-K PRIMARY DOCUMENT 2.02,9.01 0001654954-16-001249 001-32639 161812511 34 154652
2016-07-08 4 OWNERSHIP DOCUMENT 0001144204-16-112317 5029
2016-07-08 4 OWNERSHIP DOCUMENT 0001144204-16-112316 5470

Latest XBRL company facts

One latest value per concept from companyfacts (474 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 151.15M 2026-11-04 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
dei EntityPublicFloat Entity Public Float USD 2.50B 2025-06-30 2025 FY 10-K 2026-02-27 0001437749-26-006133
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 616.30M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014233
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.41M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014233
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.77M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014233
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 120 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014233
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 28.30M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014233
ecd PeoTotalCompAmt PeoTotalCompAmt USD 25.57M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014233
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 57 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001437749-26-014233
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 152,000 2014-06-30 2014 Q2 10-Q 2014-07-24 0001144204-14-044721
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 176.86M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 1.80M 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062637
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 416.82M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.87B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 60.69M 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 2.25M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 19,210 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 188,509 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062637
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 12.33M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 800,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 595,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap AdministrativeFeesExpense Administrative Fees Expense USD 367,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 64.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 779,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 159,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001437749-23-030412
us-gaap AmortizationOfLeaseIncentives Amortization of Lease Incentives USD 106,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-06 0001558370-21-010837
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 2.80M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-15 0001144204-16-088155
us-gaap Assets Assets USD 1.59B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AssetsCurrent Assets, Current USD 1.17B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 3.71M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap AvailableForSaleSecuritiesEquitySecurities Available-for-sale Securities, Equity Securities USD 175.00M 2015-12-31 2017 FY 10-K 2018-03-15 0001654954-18-002638
us-gaap BusinessAcquisitionCostOfAcquiredEntityPurchasePrice Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) USD 378,238 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 231,580 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 281,250 2011-11-29 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquired Business Acquisition, Purchase Price Allocation, Assets Acquired (Deprecated 2013-01-31) USD 4.00M 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net (Deprecated 2013-01-31) USD 378,238 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents (Deprecated 2013-01-31) USD 10,386 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillAmount Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) USD 799,391 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill Business Acquisition, Purchase Price Allocation, Intangible Assets Other than Goodwill (Deprecated 2013-01-31) USD 3.90M 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed Business Acquisition, Purchase Price Allocation, Liabilities Assumed (Deprecated 2013-01-31) USD 4.42M 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionPurchasePriceAllocationOtherAssets Business Acquisition, Purchase Price Allocation, Other Assets (Deprecated 2013-01-31) USD 90,770 2011-12-29 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -818,279 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 0 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap Cash Cash USD 399.88M 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 10,386 2011-12-01 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030472
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 429.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 2.72M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 556.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 430.75M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 430.75M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 350.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrant 2.25 2013-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 100 2014-07-18 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 1 2014-07-18 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 0.001 2014-07-18 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 147,058 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap ClearingFeesRevenue Clearing Fees Revenue (Deprecated 2018-01-31) USD 38,095 2017-10-01 2017-12-31 2017 FY 10-K 2018-03-15 0001654954-18-002638
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 190.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 160.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 151.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CommonStockValue Common Stock, Value, Issued USD 160,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ConstructionContractCostProgressPaymentOffset Construction Contract Cost, Progress Payment Offset USD 37.40M 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap ContractualObligation Contractual Obligation USD 115.43M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 4.71M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap ContractualObligationDueInFourthAndFifthYear Contractual Obligation, to be Paid, Year Four and Five USD 3.74M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 2.39M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap ContractualObligationDueInSecondAndThirdYear Contractual Obligation, to be Paid, Year Two and Three USD 104.58M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 26.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 7.07M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 4.38M 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062637
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 4.38M 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062637
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062637
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 8.89 2013-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 116.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CostOfRevenue Cost of Revenue USD 139,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001558370-21-006712
us-gaap CostsAndExpenses Costs and Expenses USD 562.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 8.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 8.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 595,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 106.37M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001437749-24-025853
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 1,125 2016-03-31 2016 Q1 10-Q 2016-05-10 0001144204-16-100475
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 95.00M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001437749-24-025853
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 3.29M 2011-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016369
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.05 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-10 0001144204-16-100475
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.05 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016369
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.09 2023-03-31 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap DebtInstrumentRepaidPrincipal DebtInstrumentRepaidPrincipal USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-09 0001437749-24-025853
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 4.40M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001437749-24-033948
us-gaap DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss USD 127.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 54.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -335.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 0 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 4.90M 2026-03-31 2026 Q1 10-Q 2026-05-06 0001437749-26-015246
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 333.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 14.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap DeferredRentCredit Deferred Rent Credit USD 800,000 2016-09-30 2016 Q3 10-Q 2016-11-09 0001654954-16-003692
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-02 0001558370-20-001897
us-gaap DeferredRevenue Deferred Revenue USD 300,000 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 16.82M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025955
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 14.53M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025955
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -12.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 0 2024-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 39.41M 2022-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 0 2013-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 391.87M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 0 2015-12-31 2015 FY 10-K 2016-03-15 0001144204-16-088155
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 348.00M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 275.71M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 27.97M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 0 2013-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 0 2015-12-31 2015 FY 10-K 2016-03-15 0001144204-16-088155
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 58.05M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 15.40M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 39.98M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 3.90M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap Depreciation Depreciation USD 173,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001437749-23-030412
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 158,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 538,830 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap DevelopmentStageEnterpriseCumulativeRevenue Development Stage Enterprise, Cumulative Revenue (Deprecated 2012-01-31) USD 0 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 46.95M 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030472
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 1.18M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD 759,134 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.63 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002617
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.205 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.076 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.068 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 15.30M 2019-12-31 2019 FY 10-K 2020-03-02 0001558370-20-001897
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2014-09-30 2014 Q3 10-Q 2014-11-14 0001144204-14-068736
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.13 2011-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap EquityMethodInvestments Equity Method Investments USD 8.48M 2012-12-31 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap EquitySecuritiesFvNiCurrentAndNoncurrent EquitySecuritiesFvNiCurrentAndNoncurrent USD 3.71M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD 2.76M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025955
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002050
us-gaap FairValueInputsDiscountRate Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) pure 0.2 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 3.29M 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -24,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 505,000 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap FinancingInterestExpense Financing Interest Expense USD 2.80M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -2.46M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD -1.21M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap GainLossOnSaleOfSecuritiesNet Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001654954-17-010322
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -9.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 107.85M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap Goodwill Goodwill USD 799,000 2024-03-31 2024 Q1 10-Q 2024-05-06 0001437749-24-014849
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 0 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap HeldToMaturitySecurities Debt Securities, Held-to-maturity USD 47.90M 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 845,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 126.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap HeldToMaturitySecuritiesUnrecognizedHoldingGains Held-to-maturity Securities, Unrecognized Holding Gain (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001654954-18-005046
us-gaap HeldToMaturitySecuritiesUnrecognizedHoldingLosses Held-to-maturity Securities, Unrecognized Holding Loss (Deprecated 2018-01-31) USD 39,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001654954-18-005046
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 1.25M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 107.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 104.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -349,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -279.38M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -750,000 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 17.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 21.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD -8.79M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations USD -41.65M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -3.77M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -4.97M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 22.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 324,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -8.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -3.51M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -6.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002050
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 7.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 68.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 111.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -10.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 6,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001558370-20-001897
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 3.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncreaseDecreaseInEquitySecuritiesFvNi Increase (Decrease) in Equity Securities, FV-NI USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD -43,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 70.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -2.37M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001437749-23-030412
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD -1.19M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -9.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -1.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001558370-20-001897
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 25,511 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -11,740 2011-04-01 2012-03-31 2012 Q1 10-Q 2012-05-14 0001144204-12-028735
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 2.23M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap IncreaseDecreaseInPrepaidRent Increase (Decrease) in Prepaid Rent USD 91,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001654954-19-009176
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 4,083 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001654954-18-002638
us-gaap InterestAndOtherIncome Interest and Other Income USD -7.61M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap InterestExpense Interest Expense USD 2.29M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-06 0001437749-24-014849
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 40.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap InterestIncomeOther Interest Income, Other USD 1.85M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001654954-19-009176
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 68,387 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 35.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016369
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 190,017 2013-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016369
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 95,000 2018-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 2.00M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap InventoryFinishedGoodsAndWorkInProcessNetOfReserves Inventory, Finished Goods and Work in Process, Net of Reserves USD 21.09M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001437749-25-033363
us-gaap InventoryNet Inventory, Net USD 194.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 20.81M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 6.58M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 4.06M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001437749-25-033363
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 6.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 31.24M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 121.81M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001437749-25-033363
us-gaap InventoryWriteDown Inventory Write-down USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 331,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 517,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap InvestmentIncomeNet Investment Income, Net USD 46,609 2011-12-01 2013-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 835,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.00M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001654954-16-003692
us-gaap LeaseCost Lease, Cost USD 1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 10.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five USD 12.06M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 2.89M 2024-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five USD 1.58M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four USD 1.59M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 1.56M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 1.55M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 393,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.83M 2024-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.24M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 530,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap Liabilities Liabilities USD 1.02B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.59B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LiabilitiesCurrent Liabilities, Current USD 260.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 38,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001654954-18-005046
us-gaap LoansPayable Loans Payable USD 102.54M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001437749-24-025853
us-gaap LoansPayableCurrent Loans Payable, Current USD 0 2024-06-30 2024 Q2 10-Q 2024-08-09 0001437749-24-025853
us-gaap LongTermDebt Long-term Debt USD 100.40M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2023-09-30 2023 Q3 10-Q 2023-11-06 0001437749-23-030412
us-gaap LongTermDebtMaturingInYearsFourAndFive Long-Term Debt, Maturity, Year Four and Five USD 0 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap LongTermDebtMaturingInYearsTwoAndThree Long-Term Debt, Maturity, Year Two and Three USD 100.40M 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 0 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 745.63M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LongTermInvestments Long-term Investments USD 56.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 102.54M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001437749-24-025853
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 7.00M 2011-04-01 2011-04-19 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 76,032 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD -76,032 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2012-12-31 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 153.56M 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 291.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 105.86M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -7.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -722,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 66.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -102.41M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 83.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -8.15M 2011-12-01 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030472
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -61.01M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 60,000 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-10 0001558370-20-010225
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -37.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap NotesIssued1 Notes Issued USD 15.50M 2010-03-01 2010-03-31 2016 Q1 10-Q 2016-05-10 0001144204-16-100475
us-gaap NotesPayable Notes Payable USD 938,000 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap NotesPayableCurrent Notes Payable, Current USD 938,000 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap NotesPayableFairValueDisclosure Notes Payable, Fair Value Disclosure USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap OperatingExpenses Operating Expenses USD 105.54M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 142.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001437749-24-006144
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 8.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.84M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 6.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OperatingLeasePaymentsUse Operating Lease, Payments, Use USD 800,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025955
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 35.35M 2018-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.36M 2018-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears Operating Leases, Future Minimum Payments, Due in Four and Five Years USD 2.74M 2018-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears Operating Leases, Future Minimum Payments, Due in Two and Three Years USD 21.05M 2018-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 10.19M 2018-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 2.70M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001558370-20-001897
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.084 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 1.30B 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002617
us-gaap OtherAccountsPayableAndAccruedLiabilities Other Accounts Payable and Accrued Liabilities USD 4.76M 2013-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap OtherAssetsCurrent Other Assets, Current USD 55.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 41.52M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap OtherIncome Other Income USD 1.29M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap OtherInventoryCapitalizedCosts Other Inventory, Capitalized Costs, Gross USD 1.15M 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.22M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-02 0001558370-20-001897
us-gaap OtherLongTermDebt Other Long-term Debt USD 95.00M 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap OtherLongTermNotesPayable Other Notes Payable, Noncurrent USD 0 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062637
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -23,917 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 11.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OtherNotesPayable Other Notes Payable USD 677,778 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062637
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 677,778 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062637
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 174.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 198.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 480,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 23.13M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD -435,938 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-15 0001144204-16-088155
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 199.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.31M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-15 0001144204-16-088155
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap PaymentsToAcquireHeldToMaturitySecurities Payments to Acquire Held-to-maturity Securities USD 49.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 23.13M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-09 0001558370-20-013410
us-gaap PaymentsToAcquireLeaseReceivables Payments to Acquire Lease Receivables USD 80,000 2014-09-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001144204-14-068736
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 1.25M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0001437749-25-015804
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 626,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap PreferredStockLiquidationPreference Preferred Stock, Liquidation Preference Per Share USD/shares 20 2012-02-24 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 0 2012-12-31 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2021-03-31 2021 Q1 10-Q 2021-05-10 0001558370-21-006712
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2021-03-31 2021 Q1 10-Q 2021-05-10 0001558370-21-006712
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2021-03-31 2021 Q1 10-Q 2021-05-10 0001558370-21-006712
us-gaap PrepaidRent Prepaid Rent USD 0 2015-12-31 2016 Q3 10-Q 2016-11-09 0001654954-16-003692
us-gaap ProceedsFromDivestitureOfInterestInJointVenture Proceeds from Divestiture of Interest in Joint Venture USD 3.20M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap ProceedsFromFeesReceived Proceeds from Fees Received USD 2.00M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001654954-16-001302
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 53.64M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 747.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 12.26M 2011-12-01 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030472
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 13.91M 2012-02-01 2012-02-24 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 150,000 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities USD 44.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 80.40M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0001437749-25-015804
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.51M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 25.00M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001437749-23-030412
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 373,433 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap ProceedsFromRepaymentsOfSecuredDebt Proceeds from (Repayments of) Secured Debt USD -255.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities Proceeds from Sale and Maturity of Held-to-maturity Securities USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap ProceedsFromSaleOfHeldToMaturitySecurities Proceeds from Sale of Held-to-maturity Securities USD 3.85M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001144204-15-029311
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 200,001 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.11M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -86.84M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 66,000 2024-03-31 2024 Q1 10-Q 2024-05-06 0001437749-24-014849
us-gaap PurchaseObligation Purchase Obligation USD 219.80M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025955
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 105.70M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025955
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 114.10M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025955
us-gaap PurchaseObligationDueInThirdYear Purchase Obligation, to be Paid, Year Three USD 92.70M 2026-03-31 2026 Q1 10-Q 2026-05-06 0001437749-26-015246
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 39.32M 2023-09-30 2023 Q3 10-Q 2023-11-06 0001437749-23-030412
us-gaap RecognitionOfDeferredRevenue Recognition of Deferred Revenue USD 100,800 2004-01-01 2004-12-31 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-21 0001144204-13-016691
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002050
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 200,001 2011-12-01 2013-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 195.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 11.89M 2001-08-06 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap RestrictedCash Restricted Cash USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.25M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap RestrictedCashAndInvestments Restricted Cash and Investments USD 1.30M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 16.05M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001558370-21-006712
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -998.99M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 705.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap RevenueRecognitionSalesReturnsReserveForSalesReturns Revenue Recognition, Sales Returns, Reserve for Sales Returns USD 600,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap Revenues Revenues USD 2.79M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.47M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001437749-23-030412
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 27.50M 2019-03-01 2021 FY 10-K 2022-03-01 0001558370-22-002617
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 5.43M 2019-12-22 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 9.2 2019-12-22 2020 FY 10-K 2021-03-01 0001558370-21-002149
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 251.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 72.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 3.34B 2020-09-30 2020 Q3 10-Q 2020-11-09 0001558370-20-013410
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares -106,046 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001654954-19-009176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 7.82 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001654954-19-009176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.27M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001654954-19-009176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 12.95 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001654954-19-009176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1.09M 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002617
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 7.76 2019-06-30 2019 Q2 10-Q 2019-08-09 0001654954-19-009176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares -620,527 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001654954-19-009176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 8.91 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001654954-19-009176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2022-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.897 2022-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.884 2022-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.034 2022-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.03 2022-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001558370-20-013410
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001558370-20-013410
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001558370-20-013410
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 147,058 2020-09-30 2020 Q3 10-Q 2020-11-09 0001558370-20-013410
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 28,026 2020-03-31 2020 Q1 10-Q 2020-05-11 0001558370-20-006304
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 82.11M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.57M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.78 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 56,250 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 2.98M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 96.67M 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.02M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.82 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 1.85B 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 2.54M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 6.63 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 25,080 2014-09-30 2014 Q3 10-Q 2014-11-14 0001144204-14-068736
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 4,194 2014-09-30 2014 Q3 10-Q 2014-11-14 0001144204-14-068736
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 49.14 2014-09-30 2014 Q3 10-Q 2014-11-14 0001144204-14-068736
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 7.22 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 12.08 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity USD 20,000 2007-01-01 2007-12-31 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap SharePrice Share Price USD/shares 5.87 2019-03-01 2021 FY 10-K 2022-03-01 0001558370-22-002617
us-gaap ShortTermInvestments Short-term Investments USD 75.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 572.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 40.45M 2023-06-30 2023 Q2 10-Q 2023-08-04 0001558370-23-013429
us-gaap StockholdersEquityNoteStockSplitConversionRatio Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) pure -56.25 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062637
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 2.20M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001144204-15-029311
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 4.10M 2019-03-01 2021 FY 10-K 2022-03-01 0001558370-22-002617
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 180,660 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 11.05M 2005-01-01 2005-12-31 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 33,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001654954-19-002189
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 34.80M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001144204-15-029311
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 5.35M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002050
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 46.30M 2023-04-01 2023-06-30 2024 Q3 10-Q 2024-11-07 0001437749-24-033948
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 322,964 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-07 0001144204-14-014207
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 252,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 568,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001558370-21-006712
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 Stock Repurchase Program, Remaining Authorized Repurchase Amount USD 0 2025-12-31 2025 FY 10-K 2026-02-27 0001437749-26-006133
us-gaap TradingSecuritiesUnrealizedHoldingGain Trading Securities, Unrealized Holding Gain USD 35,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap TradingSecuritiesUnrealizedHoldingLoss Trading Securities, Unrealized Holding Loss USD 3,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001654954-19-012751
us-gaap TreasuryStockAcquiredAverageCostPerShare Treasury Stock Acquired, Average Cost Per Share USD/shares 28.55 2024-08-02 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025955
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 8.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 300.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap TreasuryStockShares Treasury Stock, Shares shares 41,309 2022-12-31 2022 FY 10-K 2023-03-01 0001558370-23-002610
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 3.50M 2024-08-02 2026-06-30 2026 Q2 10-Q 2026-08-05 0001437749-26-025955
us-gaap TreasuryStockValue Treasury Stock, Value USD 300.22M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 100.00M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 3.83M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001437749-24-025853
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -987 2006-01-01 2006-12-31 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2024-12-31 2024 FY 10-K 2025-03-03 0001437749-25-005908
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -371.70M 2025-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2011-09-30 2011 Q3 10-Q 2011-11-14 0001144204-11-063558
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 15.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 157.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 132.22M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002617
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 142.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072257
us-gaap WeightedAverageNumberOfSharesRestrictedStock Weighted Average Number of Shares, Restricted Stock shares 110,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001654954-18-005046

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →